Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
Jorne UbachsJanine ZiemonsIris J G Minis-RuttenRoy F P M KruitwagenJos KleijnenSandrina LambrechtsSteven W M Olde DaminkSander S RensenToon Van GorpPublished in: Journal of cachexia, sarcopenia and muscle (2019)
Whereas our meta-analysis indicated that a low SMI and low SMRA are associated with survival in ovarian cancer patients, the low quality of the source data precludes drawing definitive conclusions.